Research Tracker›Biomarker Atlas›Marker Pages›Anti-STAB1 autoantibodies

Anti-STAB1 autoantibodies: biomarker evidence

Anti-STAB1 autoantibodies appears in 1 entry of the OSMF biomarker atlas, covering PACVS. Across those entries it is elevated in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

PACVS

Where Anti-STAB1 autoantibodies is reported

Also listed as: Stabilin-1

ConditionDirectionCompared againstAssociated symptomsSource
PACVS↑ elevatedhealthy controlsSkin edema, rashMantovani et al. 2024

Frequently asked questions

In which conditions is Anti-STAB1 autoantibodies altered?

In the OSMF atlas Anti-STAB1 autoantibodies is reported in PACVS. It is elevated in 1 across 1 entries.

Is there a standard clinical test for Anti-STAB1 autoantibodies?

The atlas entries for Anti-STAB1 autoantibodies do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal Anti-STAB1 autoantibodies result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Anti-STAB1 autoantibodies across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/anti-stab1-autoantibodies.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-30 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.